{
    "Trade/Device Name(s)": [
        "LIAISON\u00ae VCA IgG",
        "LIAISON\u00ae VCA IgG Serum Control Set",
        "LIAISON\u00ae EBNA IgG",
        "LIAISON\u00ae EBNA IgG Serum Control Set"
    ],
    "Submitter Information": "DiaSorin Inc.",
    "510(k) Number": "K162961",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040120"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LSE",
        "LLM",
        "JJX"
    ],
    "Summary Letter Date": "October 21, 2016",
    "Summary Letter Received Date": "December 6, 2016",
    "Submission Date": "October 21, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.3235"
    ],
    "Regulation Name(s)": [
        "Epstein-Barr virus serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "serology"
    ],
    "Analyte(s)": [
        "IgG antibodies to Epstein-Barr virus (EBV) viral capsid antigen (VCA)",
        "IgG antibodies to Epstein-Barr virus (EBV) nuclear antigen (EBNA-1)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "LIAISON\u00ae Analyzer family",
        "LIAISON\u00ae XL"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay (CLIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Serum Control Set",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for DiaSorin LIAISON VCA IgG, EBNA IgG assays and corresponding Serum Control Sets for qualitative detection of EBV-specific IgG antibodies using chemiluminescent immunoassay on LIAISON platforms.",
    "Indications for Use Summary": "Qualitative determination of specific IgG antibodies to EBV VCA or EBNA in human serum as an aid, with other EBV markers, in laboratory diagnosis of Epstein-Barr Viral Syndrome in patients with signs and symptoms of EBV infection such as infectious mononucleosis; Serum Control Sets used to monitor assay performance on LIAISON analyzers.",
    "fda_folder": "Microbiology"
}